GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

NSE:GLAXO Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	494,115	329,173	224,319	281,714	244,012	210,953
Market Cap Growth	18.69%	46.74%	-20.37%	15.45%	15.67%	-4.20%
Enterprise Value	473,155	313,334	211,499	270,099	237,483	201,694
Last Close Price	2916.00	1913.82	1273.47	1509.17	1279.61	1087.91
PE Ratio	57.51	55.80	36.73	16.62	68.13	226.33
PS Ratio	13.34	9.53	6.90	8.59	8.34	6.54
PB Ratio	29.54	18.52	12.88	10.58	16.51	11.59
P/TBV Ratio	29.87	18.77	13.14	10.72	17.01	11.91
P/FCF Ratio	-	59.76	50.96	36.30	45.72	63.05
P/OCF Ratio	-	56.56	46.33	34.75	42.22	43.01
EV/Sales Ratio	12.77	9.07	6.50	8.24	8.12	6.26
EV/EBITDA Ratio	43.35	35.58	26.83	36.36	41.42	31.37
EV/EBIT Ratio	45.88	37.35	28.26	38.65	45.71	34.36
EV/FCF Ratio	-	56.89	48.05	34.80	44.50	60.28
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.02
Debt / EBITDA Ratio	0.01	0.02	0.02	0.03	0.06	0.06
Debt / FCF Ratio	-	0.03	0.04	0.03	0.07	0.13
Asset Turnover	-	1.00	0.82	0.85	0.94	0.92
Inventory Turnover	-	2.75	2.62	2.55	2.49	2.73
Quick Ratio	-	1.45	1.50	1.83	1.02	1.17
Current Ratio	-	1.84	1.88	2.18	1.63	1.74
Return on Equity (ROE)	-	33.53%	27.59%	18.39%	17.42%	4.71%
Return on Assets (ROA)	-	15.24%	11.75%	11.28%	10.39%	10.42%
Return on Capital (ROIC)	39.68%	29.52%	21.07%	20.82%	19.24%	18.33%
Return on Capital Employed (ROCE)	-	41.30%	37.40%	23.80%	29.50%	27.80%
Earnings Yield	1.74%	1.79%	2.72%	6.02%	1.47%	0.44%
FCF Yield	-	1.67%	1.96%	2.76%	2.19%	1.59%
Dividend Yield	1.57%	1.67%	2.51%	1.99%	2.34%	1.84%
Payout Ratio	-	91.80%	249.80%	29.89%	189.04%	363.51%
Total Shareholder Return	1.53%	1.67%	2.51%	1.99%	2.34%	1.84%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.